Rebuya, Madilyn P.
HRN: 27-74-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/05/2026
06/12/2026
IV
500mg
Q 8
Aspiration Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes